Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type of vision loss known as nonarteritic anterior ischemic optic neuropathy (NAION). This condition can l…
During a recent segment on the Today show, co-host Craig Melvin humorously responded to Dylan Dreyer's inquiry about whether he has used GLP-1 medications for weight loss. The exc…
A recent study published in Childhood Obesity highlights a concerning trend among children taking GLP-1 medications for weight management and diabetes. The study found that nearly…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
Numerous lawsuits have been initiated in the United States against companies producing GLP-1 medications, such as Ozempic and Mounjaro, claiming these drugs may lead to a rare eye…
As GLP-1 medications gain popularity for weight loss, their use among college women during sorority recruitment raises concerns about body image pressures. A recent analysis indic…
As millions of individuals take GLP-1 medications like Ozempic and Wegovy, understanding how to safely fast for Yom Kippur becomes essential. While most can participate in fasting…
A recent study from NYU Langone Health indicates that men genetically predisposed to androgenetic alopecia may face a 7% increased risk of hair loss when using GLP-1 drugs such as…
Recent research indicates that semaglutide, a drug used for weight loss, may also extend lifespan and improve health measures in elderly mice. While the findings are intriguing, t…
A recent NIH-funded study indicates that semaglutide, a key ingredient in GLP-1 drugs like Ozempic, may extend lifespan and improve various health markers in older mice. The resea…
A recent analysis published in the Journal of the Endocrine Society suggests that visceral fat, rather than aging, plays a more significant role in lowering testosterone levels in…
A recent analysis reveals that prescription rates for GLP-1 weight-loss medications, such as Wegovy and Mounjaro, are significantly lower in England's most deprived areas, despite…
As 'Ozempic face' becomes a trending concern after weight loss from GLP-1 medications, surgeons adapt by offering innovative treatments to restore youthful facial volume and featu…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
Eli Lilly is targeting a revenue milestone of $100 billion by fiscal 2026, supported by strong growth in its incretin franchise and a bullish price target of $1,480. The company's…